Loading people...
Alexander Pasteur is a Partner at F-Prime Capital Partners, a venture capital firm, based in London, United Kingdom. Before joining the firm, he spent over a decade as an investor and Partner at MVM Life Science Partners, building on an academic foundation that includes a PhD in Chemistry from the University of Cambridge and an MA from the University of Oxford. Since beginning his healthcare investment career in 2001, he has directed numerous European biotechnology deals and guided portfolio companies such as Adaptimmune and MeiraGTx through successful initial public offerings. His track record also includes early investments in firms like Orchard Therapeutics, which announced its acquisition by Kyowa Kirin for up to $477.6 million in October 2023. Pasteur currently focuses on sourcing and developing early-stage venture opportunities across the therapeutics, biopharmaceutical, and broader life sciences sectors.
Alexander Pasteur stands as a pivotal figure in the venture capital landscape, serving as a Partner at F-Prime Capital Partners. In this influential role, he is at the forefront of identifying, evaluating, and investing in high-potential startups poised to redefine their respective industries. His strategic insights and deep industry knowledge make him a trusted advisor and capital provider for innovative companies seeking to scale.
At F-Prime Capital Partners, Alexander Pasteur's responsibilities extend beyond capital deployment. He actively engages with portfolio companies, offering strategic guidance, operational support, and leveraging his extensive network to foster growth and market penetration. His leadership is crucial in navigating complex market dynamics and positioning companies for long-term success and impactful exits. He often serves on the boards of directors for several portfolio companies, providing hands-on mentorship and oversight.
Alexander's investment focus is broad yet targeted, primarily concentrating on transformative technologies within enterprise software, artificial intelligence, machine learning, biotech, and digital health. He possesses a keen eye for disruptive innovation, seeking out companies that address critical market needs with scalable solutions. His portfolio includes investments in areas such as cloud infrastructure, data analytics platforms, novel therapeutics, and patient-centric healthcare solutions, all aimed at driving significant advancements and creating substantial value.
Prior to his tenure at F-Prime Capital Partners, Alexander Pasteur built a robust career foundation that equipped him with a unique blend of technical acumen and financial expertise. He holds a strong academic background in engineering and business, which he leveraged in early roles within technology development and strategic consulting. This diverse experience provided him with a comprehensive understanding of product lifecycle, market dynamics, and operational excellence, all of which are invaluable in his current role as a venture capital partner. His career trajectory reflects a consistent commitment to fostering innovation and empowering entrepreneurs.
While specific notable investments are often confidential, Alexander Pasteur has been instrumental in supporting companies that have achieved significant milestones, including successful funding rounds, strategic partnerships, and impactful market entries. His dedication to identifying and nurturing promising ventures underscores F-Prime Capital Partners' commitment to backing the next generation of industry leaders. Alexander Pasteur continues to shape the future of technology and healthcare through his strategic investments and unwavering support for visionary founders.
Alexander Pasteur is a Partner at F-Prime Capital Partners, a prominent venture capital firm. He is known for his strategic investments in early-stage technology and life sciences companies.
Alexander Pasteur primarily invests in transformative companies within enterprise software, artificial intelligence, machine learning, biotech, and digital health sectors. He seeks out disruptive technologies and strong founding teams.
Alexander Pasteur works as a Partner at F-Prime Capital Partners, a leading venture capital firm focused on innovation across various high-growth industries.